Nishino M, Gargano M, Suda M, Ramaiya NH, Hodi FS. Optimizing immune -related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab? J I mmunot her Cancer 2014;2:17.